Biocon Biologics

Biocon Biologics

A fully integrated pure play biosimilars organization, globally engaged in developing high quality affordable biosimilars.

Launch date
Employees
Market cap
-
Enterprise valuation
AUD7.6b (Public information from May 2022)
Krishnasagara India (HQ)
  • Edit
DateInvestorsAmountRound

$150m

Valuation: $3.9b

Growth Equity VC
*
N/A

N/A

Debt
Total FundingAUD232m

Recent News about Biocon Biologics

Edit

Investments by Biocon Biologics

Edit
Covidshield Technologies
ACQUISITION by Biocon Biologics Jun 2022